Alan M Fogelman MD
Adult Congenital Heart Disease
Professor of Medicine, UCLA
Join to View Full Profile
10833 LeConte Ave., 37-120 CHSLos Angeles, CA 90095
Phone+1 310-825-6058
Fax+1 310-825-6058
Dr. Fogelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1971 - 1972- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1970 - 1971
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1967 - 1968
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1966 - 1967
David Geffen School of Medicine at UCLAClass of 1966
Certifications & Licensure
CA State Medical License 1967 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- 2 citationsEvidence further linking the intestine to cardiovascular disease.Dawoud Sulaiman, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology. 2024-10-01 - 5 citationsThe multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis.Arnab Chattopadhyay, Srinivasa T Reddy, Alan M Fogelman
Current Opinion in Lipidology. 2023-10-01 - 7 citationsRole of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis.Arnab Chattopadhyay, Pallavi Mukherjee, Dawoud Sulaiman, Huan Wang, Victor Girjalva
Journal of Lipid Research. 2023-05-01
Press Mentions
Pioneering Center for East-West Medicine Celebrates 30 Years at UCLA HealthOctober 15th, 2024- Is the Relationship Between Diet, Intestinal Bacteria and Cells Key to Preventing Systemic Inflammation?November 22nd, 2021
Grant Support
- An In-Vitro And In-Vivo Approach To Artery Wall InflammationNational Heart, Lung, And Blood Institute2009–2012
- Accounting And Administrative Services CoreNational Heart, Lung, And Blood Institute2009–2012
- Lipid And Lipoprotein Metabolism In AtherosclerosisNational Heart, Lung, And Blood Institute1985–2012
- Lipid And Lipoprotein Metabolism In Atherosclerosis (Core A)National Center For Research Resources2004–2010
- In Vitro And In Vivo Approach To Artery Wall InflammationNational Heart, Lung, And Blood Institute2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
